Program Publications

Following is a list of publications about the work of the UF Health Personalized Medicine Program.

 

Citation Date PubMed ID
Cavallari LH, Weitzel KM. Pharmacogenomics in cardiology – genetics and drug response: 10 years of progress. (Invited commentary) Future Cardiol. 2015 May;11(3):281-6. May-15 26021633
Langaee TY, Hamadeh IS, Chapman AB, Gums JG, Johnson JA. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication. PLoS One. 2015 Jan 27;10(1). Jan-15 25625348
Johnson JA, Hamadeh IS, Langaee TY.  Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for tamoxifen pharmacogenetic studies. J Natl Cancer Inst. 2015 Jan 31;107(2). Jan-15 25638249
Owusu-Obeng A, Weitzel KW, Hatton RC, Staley BJ, Ashton J, Cooper-Dehoff RM, Johnson JA. Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy. 2014 Sep 15 [Epub ahead of print]. Sept-14 25220280
Langaee TY, Zhu HJ, Wang X, et al. The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping. Pharmacogenet Genomics. 2014 Aug;24(8):381-6. Aug-14 24945780
Owusu Obeng A, Egelund EF, Alsultan A, et al. CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics? Pharmacotherapy. 2014 Jul;34(7):703-18. Jul-14 24510446
Ramsey LB, Johnson SG, Caudle KE, et al. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update. Clin Pharmacol Ther. 2014 Jun 11. Jun-14 24918167
Weitzel KW, Elsey AR, Langaee TY, et al. Clinical pharmacogenetics implementation: approaches, successes, and challenges. Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):56-67. Mar-14 24616371
Perera MA, Cavallari LH, Johnson JA. Warfarin pharmacogenetics: an illustration of the importance of studies in minority populations. Clin Pharmacol Ther. 2014 Mar;95(3):242-4. Mar-14 24548987
Muir AJ, Gong L, Johnson SG, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens. Clin Pharmacol Ther. 2014 Feb;95(2):141-6. Oct-13 24096968
Shuldiner AR, Relling MV, Peterson JF, et al. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther. 2013 Aug;94(2):207-10. Aug-13 23588301
Johnson JA, Elsey AR, Clare-Salzler MJ, et al. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. Pharmacogenomics. 2013 May;14(7):723-6. May-13 23651020
Johnson JA, Klein TE, Relling MV. Clinical implementation of pharmacogenetics: more than one gene at a time. Clin Pharmacol Ther. 2013 May;93(5):384-5. May-13 23598455
Scott SA, Sangkuhl K, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013 Sep;94(3):317-23. May-13 23698643
Johnson JA, Burkley BM, Langaee TY, et al. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.Clin Pharmacol Ther. 2012 Oct;92(4):437-9. Oct-12 22910441
Johnson JA, Roden DM, Lesko LJ, Ashley E, Klein TE, Shuldiner AR. Clopidogrel: a case for indication-specific pharmacogenetics. Clin Pharmacol Ther. 2012 May;91(5):774-6. May-12 22513313
Nelson DR, Conlon M, Baralt C, Johnson JA, Clare-Salzler MJ, Rawley-Payne M. University of Florida Clinical and Translational Science Institute: transformation and translation in personalized medicine.Clin Transl Sci. 2011 Dec; 4(6):400-2. Dec-11 22212220
Roden DM, Johnson JA, Kimmel SE, Krauss RM, Medina MW, Shuldiner A, Wilke RA. Cardiovascular pharmacogenomics. Circ Res. 2011 Sep 16;109(7):807-20. Sep-11 21921273
Johnson JA, Cavallari LH, Beitelshees AL, et al. Pharmacogenomics: application to the management of cardiovascular disease. Clin Pharmacol Ther. 2011 Oct;90(4):519-31. Oct-11 21918509
Scott SA, Sangkuhl K, Gardner EE, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin Pharmacol Ther. 2011 Aug;90(2):328-32. Jun-11 21716271